-
2024-512945-18-00
5
2021-11-30
Geographic Atrophy Secondary to Age-Related Macular Degeneration
-
2024-517251-12-00
5
2021-11-02
Recurrent or metastatic head and neck squamous cell carcinoma
-
2023-506170-12-00
4
2021-10-18
Alzheimer’s Disease
-
2024-512345-16-00
4
2021-10-13
Chronic inflammatory demyelinating polyradiculoneuropathy
-
2023-510057-41-00
5
2021-10-06
Patients With Homozygous and Heterozygous Familial Hypercholesterolemi
-
2024-510744-31-00
5
2021-10-06
Giant cell arteritis (GCA)
-
2022-502774-17-00
7
2021-10-04
Advanced or metastatic gastric and gastro-esophageal junction (GEJ) ad
-
2024-512717-41-00
4
2021-10-01
Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas
-
2024-518943-38-00
5
2021-09-15
refractory chronic cluster headache
-
2023-510046-25-00
7
2021-09-02
Soild Tumors
-
2024-511728-15-00
7
2021-08-26
Solid tumors
-
2023-507096-21-00
5
2021-08-16
Chronic or Episodic Migraine (Migraine without aura, migraine with aur
-
2023-505203-23-01
5
2021-07-26
Severe asthma with an eosinophilic phenotype
-
2024-512689-32-00
3
2021-07-15
Non-Hodgkin lymphoma and chronic lymphocytic leukemia
-
2022-500573-13-00
1
2021-07-06
Relapsed or Refractory Acute Myeloid Leukemia
-
2023-506315-17-00
9
2021-06-25
Advanced melanoma with brain metastases, PD-1 refractory or PD-1 naiv
-
2024-511035-10-00
5
2021-06-23
Hidradenitis Suppurativa
-
2024-513672-17-00
4
2021-06-14
Inoperable Chronic thromboembolic pulmonary hyperTension
-
2023-510230-84-00
5
2021-05-28
Severe asthma with an eosinophilic phenotype
-
2024-512123-37-00
5
2021-05-27
Parkinson's disease
-
2023-506918-45-00
5
2021-05-17
Mild cognitive impairment (MCI) or mild dementia, both of the Alzheime
-
2023-506919-18-00
5
2021-05-17
Mild cognitive impairment (MCI) or mild dementia, both of the Alzheime
-
2024-515510-41-00
4
2021-04-28
Head and neck cancer
-
2023-508485-15-00
5
2021-04-22
Subjects with documented STEMI, presenting with persistent ischemic ch